BRF
ALIM

B. Riley Financial’s Alimera Sciences ALIM Stock Holding History

B. Riley Financial’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19,067
Closed -$303K – 89
2019
Q1 		$303K Sell
19,067
-9,640
-34% -$147K 0.12% 64
2018
Q4 		$309K Sell
28,707
-1,706
-6% -$24.9K 0.17% 64
2018
Q3 		$447K Buy
+30,413
New +$463K 0.13% 117

Other funds holding ALIM

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

B. Riley Financial's ALIM Position: Q2 2019 in Review

B. Riley Financial sold out of Alimera Sciences (ALIM) in Q2 2019, closing a stake of 19,067 shares — an estimated $303K sold.

B. Riley Financial first reported a position in ALIM in Q3 2018 and held it in 3 quarters. The position peaked at $447K in Q3 2018. 41 funds tracked by Wall St. Rank hold ALIM as of Q2 2019.

  • B. Riley Financial reported no remaining Alimera Sciences position as of Q2 2019 after selling out during the quarter.
  • B. Riley Financial sold 19,067 Alimera Sciences shares in Q2 2019, an estimated $303K.
  • B. Riley Financial first reported a position in Alimera Sciences in Q3 2018 and held it in 3 quarters.
  • B. Riley Financial's Alimera Sciences position peaked at $447K in Q3 2018.
  • 41 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2019.

Based on B. Riley Financial's 13F filing for Q2 2019, filed 12 Aug 2019.